Miami Cancer Institute at Baptist Health

Miami, Florida 33176

2 studies enrolling now · 7 studies all time

What they study most

Brain Tumor, Breast Cancer Female, Breast Cancer Metastatic, Coronavirus Infection, Glioblastoma, Glioma, Gliosarcoma, HR+/HER2-negative Breast Cancer, Her 2 Positive Breast Cancer, Liquid Biopsy, Metastatic Breast Cancer, Non Small Cell Lung Cancer

Studies at this site

• Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets — Recruiting now
• Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer — Recruiting now
• A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN) — Running, not enrolling
• Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors — Completed
• A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies — Completed
• Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection — Completed
• Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma — Stopped early